Abbreviations: 3,5-DHPG, 3,5-dihydroxyphenylglycine; 5-HT, 5-hydroxytryptamine or serotonin; AC, adenylate cyclase; ACPD, 1-amino-1,3-dicarboxycyclopentane; Alpha-MPT, alphamethyl-DL-p-tyrosine methyl ester; AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMPH, amphetamine; APDC, dihydroxyphenylglycine; ASST, attentional set-shifting task; ATP, cytosolic adenosine triphosphate; BINA, biphenylindanone A; cAMP, cyclic-adenosine monophosphate; Csk, c-terminal of Src kinase; DA, dopamine; DCG-IV, (2S,1′R,2′ R,3′R)-2-(2,3-dicarboxycyclopropyl) glycine; DIV, days in vitro; DOI, 2,5-dimethoxy-4-iodoamphetamine; DRL72, differential reinforcement of a low-rate 72s; DTI, diffusion tensor imaging; Erk1/2, extracellular signal-regulated kinase1/2; fEPSP, field excitatory post-synaptic potential; GABA, gamma-aminobutyric acid; Gsk-3β, glycogen synthase kinase 3β; HSP, heat shock protein; i.c.v, intracerebroventricular; I.P., intraperitoneal; KO, knock out; LTD, long term depression; LTP, long term potentiation; MAPH, methamphetamine; mGluRs, metabotropic glutamate receptors; MK-801, dizocilpine; NMDA, N-methyl-D-aspartate; NSF, N-ethylmaleimide-sensitive factor; P.O., per os; PAMs, positive allosteric modulators; PCP, phencyclidine; PCPA, DL-pchlorophenylalanine; PD, Parkinson's disease; PKA, protein kinase A; PKC, protein kinase C; PVT, paraventricular thalamic nucleus; s.c, subcutaneous; SLM, stratum lacunosum moleculare; SNAP, soluble NSF activating protein; SNARE, soluble NSF activating protein receptor; SNP, single nucleotide polymorphism; SZ, schizophrenia; TAP, temporo-ammonic path; VAMP, vesicle-associated membrane protein.
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